Inventor · disambiguated record
Changshou Gao
Also filed as: GAO CHANGSHOU
34 granted patents·25 pending applications·445 citations·filing 1999–2025
97Inventor score
Top patents by PatentIndex Score
59 records- 0198US8409568B2Mutant antibody Fc domains and fusion proteins thereofGAO CHANGSHOU·Filed 2010·Granted Apr 2, 2013·97 cites·12 claims
- 0297US7790655B2Cell display of antibody librariesMEDIMMUNE LLC·Filed 2006·Granted Sep 7, 2010·36 cites·15 claims
- 0395US10442854B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Oct 15, 2019·13 cites·11 claims
- 0495US7659374B2Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activityMEDIMMUNE LLC·Filed 2005·Granted Feb 9, 2010·28 cites·14 claims
- 0593US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0693US6472147B1Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial librariesSCRIPPS RESEARCH INST·Filed 1999·Granted Oct 29, 2002·141 cites·5 claims
- 0792US10744204B2Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2015·Granted Aug 18, 2020·8 cites·15 claims
- 0892US8697650B2HSA-related compositions and methods of useGAO CHANGSHOU·Filed 2011·Granted Apr 15, 2014·29 cites·30 claims
- 0992US7585504B2High affinity antibodies against HMGB1 and methods of use thereofMEDIMMUNE LLC·Filed 2005·Granted Sep 8, 2009·21 cites·16 claims
- 1090US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 1189USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 1289US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 1389US10882897B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Jan 5, 2021·3 cites·14 claims
- 1489US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 1587US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1685US7964706B2High affinity antibodies against HMGB1 and methods of use thereofMEDIMMUNE LLC·Filed 2006·Granted Jun 21, 2011·10 cites·16 claims
- 1784US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 1882US11926657B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2022·Granted Mar 12, 2024·0 cites·13 claims
- 1982US9120875B2HSA-related compositions and methods of useMEDIMMUNE LLC·Filed 2014·Granted Sep 1, 2015·4 cites·20 claims
- 2082US9045564B2HSA-related compositions and methods of useGAO CHANGSHOU·Filed 2011·Granted Jun 2, 2015·6 cites·22 claims
- 2181US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 2281US8153131B2High affinity antibodies against HMGB1 and methods of use thereofWU HERREN·Filed 2009·Granted Apr 10, 2012·4 cites·18 claims
- 2379US11192931B2Relaxin fusion polypeptides and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Dec 7, 2021·2 cites·15 claims
- 2479US8129130B2High affinity antibodies against HMGB1 and methods of use thereofWU HERREN·Filed 2011·Granted Mar 6, 2012·5 cites·4 claims
- 2577US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 2676US9567389B2Cell display of antibody librariesMEDIMMUNE LLC·Filed 2013·Granted Feb 14, 2017·1 cites·20 claims
- 2775US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 2872US7078166B2Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial librariesSCRIPPS RESEARCH INST·Filed 2002·Granted Jul 18, 2006·3 cites·10 claims
- 2972US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 3071US11524993B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Dec 13, 2022·0 cites·14 claims
- 3168US11845782B2Relaxin fusion polypeptides and uses thereofMEDIMMUNE LTD·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
- 3268US2023321267A1Method And MoleculesMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 3367US11634483B2Nucleic acids encoding anti-VEGF-A antibodies and uses thereofMEDIMMUNE LTD·Filed 2021·Granted Apr 25, 2023·0 cites·4 claims
- 3466US11566068B2Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2020·Granted Jan 31, 2023·0 cites·4 claims
- 3562US2010203045A1EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITYMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 3662US2022160882A1Method of conjugating a polypeptideMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 3762US2009155275A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 3861US10836819B2Anti-VEGF-A and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Nov 17, 2020·0 cites·7 claims
- 3960US11759526B2Method and moleculesMEDIMMUNE LLC·Filed 2018·Granted Sep 19, 2023·0 cites·5 claims
- 4060US2025152728A1Method And MoleculesMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 4160US2021069341A1Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
- 4259US2011033378A1Cysteine Engineered Antibodies For Site-Specific ConjugationMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 4358US10919958B2Anti-VEGF-A antibodies and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Feb 16, 2021·0 cites·5 claims
- 4458US2011059100A1C/CLP Antagonists And Methods Of Use ThereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 4556US2013295098A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 4652US2011076752A1Antibody library display by yeast cell plasma membraneMEDIMMUNE LLC·Filed 2008·Application pending·0 cites
- 4748US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 4848US2010233173A1Multispecific epitope binding proteins and uses thereofMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 4946US2017183414A1Cysteine engineered antibodies for site-specific conjugationMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 5045US2006094062A1Ultra high throughput capture lift screening methodsMEDIMMUNE INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Changshou Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →